T1	p 140 172	patients undergoing laparatomy .
T2	p 450 482	patients undergoing laparotomy .
T3	p 491 563	Eighty patients ( 18 to 65 years of age ) undergoing elective laparotomy
T4	p 1921 1953	patients undergoing laparotomy .
T5	p 2049 2081	patients undergoing laparatomy .
T6	i 21 98	preoperative oral pregabalin and perioperative intravenous lidocaine infusion
T7	i 241 300	pregabalin and perioperative intravenous lidocaine infusion
T8	i 638 672	placebo capsules and normal saline
T9	i 722 760	placebo capsules and lidocaine 1 mg?kg
T10	i 796 805	2 mg?kg?h
T11	i 826 835	closure ;
T12	i 853 911	oral pregabalin and normal saline infusion perioperatively
T13	i 942 993	mg oral pregabalin and lidocaine 2 mg?kg?h infusion
T14	i 1322 1330	Morphine
T15	i 1620 1630	pregabalin
T16	i 1635 1670	perioperative intravenous lidocaine
T17	i 1735 1745	pregabalin
T18	i 1807 1816	lidocaine
T19	i 1979 1989	pregabalin
T20	i 1998 2015	without lidocaine
T21	o 304 446	postoperative morphine requirement , adverse effects , patients ' satisfaction , mobilization , time to first defecation and time to discharge
T22	o 1015 1213	Hemodynamic parameters , visual analogue scale ( VAS ) scores , analgesic consumption , side effects , time to mobilization , time to first defecation , time to discharge and patients ' satisfaction
T23	o 1238 1248	VAS scores
T24	o 1405 1424	Incidence of nausea
T25	o 1475 1516	Time to first defecation and mobilization
T26	o 1690 1716	postoperative VAS scores .
T27	o 1756 1877	morphine requirement and perioperative intravenous lidocaine infusion hastened gastrointestinal motility and mobilization
T28	o 1911 1917	nausea
T29	o 2034 2045	pain relief